GEHC

SEC source: 0000899243-23-001113 · doc4.xml · derivative · entry 6

Makela Jan · CIK 0001951803 · CEO, Imaging

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 7,345

Underlying: Common stock, par value $0.01 per share · 7,345 shares

Expires 2026-09-30

F1 · price: The transactions reported herein are the result of the consummation on January 3, 2023 of the distribution of approximately 80.1% of the shares of common stock of GE HealthCare Technologies Inc. ("GE HealthCare") by General Electric Company ("GE") to holders of GE common stock on a pro rata basis (the "Spin-Off"). These transactions are voluntarily reported notwithstanding the exemption provided by Rule 16a-9.

F2 · derivative.exercise_date: Award of an employee stock option with respect to GE HealthCare common stock resulting from the conversion of certain equity incentive awards previously granted by GE as a result of the Spin-Off, of which 100% is fully exercisable immediately.

SEC source: 0000899243-23-001113 · doc4.xml · derivative · entry 5

Makela Jan · CIK 0001951803 · CEO, Imaging

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 4,408

Underlying: Common stock, par value $0.01 per share · 4,408 shares

Expires 2025-09-11

F1 · price: The transactions reported herein are the result of the consummation on January 3, 2023 of the distribution of approximately 80.1% of the shares of common stock of GE HealthCare Technologies Inc. ("GE HealthCare") by General Electric Company ("GE") to holders of GE common stock on a pro rata basis (the "Spin-Off"). These transactions are voluntarily reported notwithstanding the exemption provided by Rule 16a-9.

F2 · derivative.exercise_date: Award of an employee stock option with respect to GE HealthCare common stock resulting from the conversion of certain equity incentive awards previously granted by GE as a result of the Spin-Off, of which 100% is fully exercisable immediately.

SEC source: 0000899243-23-001113 · doc4.xml · derivative · entry 4

Makela Jan · CIK 0001951803 · CEO, Imaging

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 2,328

Underlying: Common stock, par value $0.01 per share · 2,328 shares

Expires 2024-09-05

F1 · price: The transactions reported herein are the result of the consummation on January 3, 2023 of the distribution of approximately 80.1% of the shares of common stock of GE HealthCare Technologies Inc. ("GE HealthCare") by General Electric Company ("GE") to holders of GE common stock on a pro rata basis (the "Spin-Off"). These transactions are voluntarily reported notwithstanding the exemption provided by Rule 16a-9.

F2 · derivative.exercise_date: Award of an employee stock option with respect to GE HealthCare common stock resulting from the conversion of certain equity incentive awards previously granted by GE as a result of the Spin-Off, of which 100% is fully exercisable immediately.

SEC source: 0000899243-23-001113 · doc4.xml · derivative · entry 3

Makela Jan · CIK 0001951803 · CEO, Imaging

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 206

Underlying: Common stock, par value $0.01 per share · 206 shares

Expires 2024-09-05

F1 · price: The transactions reported herein are the result of the consummation on January 3, 2023 of the distribution of approximately 80.1% of the shares of common stock of GE HealthCare Technologies Inc. ("GE HealthCare") by General Electric Company ("GE") to holders of GE common stock on a pro rata basis (the "Spin-Off"). These transactions are voluntarily reported notwithstanding the exemption provided by Rule 16a-9.

F2 · derivative.exercise_date: Award of an employee stock option with respect to GE HealthCare common stock resulting from the conversion of certain equity incentive awards previously granted by GE as a result of the Spin-Off, of which 100% is fully exercisable immediately.

SEC source: 0000899243-23-001113 · doc4.xml · derivative · entry 2

Makela Jan · CIK 0001951803 · CEO, Imaging

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 1,469

Underlying: Common stock, par value $0.01 per share · 1,469 shares

Expires 2023-09-13

F1 · price: The transactions reported herein are the result of the consummation on January 3, 2023 of the distribution of approximately 80.1% of the shares of common stock of GE HealthCare Technologies Inc. ("GE HealthCare") by General Electric Company ("GE") to holders of GE common stock on a pro rata basis (the "Spin-Off"). These transactions are voluntarily reported notwithstanding the exemption provided by Rule 16a-9.

F2 · derivative.exercise_date: Award of an employee stock option with respect to GE HealthCare common stock resulting from the conversion of certain equity incentive awards previously granted by GE as a result of the Spin-Off, of which 100% is fully exercisable immediately.

SEC source: 0000899243-23-001111 · doc4.xml · derivative · entry 16

O'Neill Kevin Michael · CIK 0001951605 · CEO, PDx

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 9,106

Underlying: Common stock, par value $0.01 per share · 9,106 shares

Expires not disclosed

F4 · derivative.exercise_price: Each restricted stock unit represents the right to receive, at settlement, one share of GE HealthCare common stock.

F1 · price: The transactions reported herein are the result of the consummation on January 3, 2023 of the distribution of approximately 80.1% of the shares of common stock of GE HealthCare Technologies Inc. ("GE HealthCare") by General Electric Company ("GE") to holders of GE common stock on a pro rata basis (the "Spin-Off"). These transactions are voluntarily reported notwithstanding the exemption provided by Rule 16a-9.

F8 · derivative.exercise_date: Award of restricted stock units with respect to GE HealthCare common stock resulting from the conversion of certain equity incentive awards previously granted by GE as a result of the Spin-Off, of which 50% will vest on March 1, 2024 and 50% will vest on March 1, 2025.

F8 · derivative.expiration_date: Award of restricted stock units with respect to GE HealthCare common stock resulting from the conversion of certain equity incentive awards previously granted by GE as a result of the Spin-Off, of which 50% will vest on March 1, 2024 and 50% will vest on March 1, 2025.

SEC source: 0000899243-23-001111 · doc4.xml · derivative · entry 15

O'Neill Kevin Michael · CIK 0001951605 · CEO, PDx

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 5,568

Underlying: Common stock, par value $0.01 per share · 5,568 shares

Expires not disclosed

F4 · derivative.exercise_price: Each restricted stock unit represents the right to receive, at settlement, one share of GE HealthCare common stock.

F1 · price: The transactions reported herein are the result of the consummation on January 3, 2023 of the distribution of approximately 80.1% of the shares of common stock of GE HealthCare Technologies Inc. ("GE HealthCare") by General Electric Company ("GE") to holders of GE common stock on a pro rata basis (the "Spin-Off"). These transactions are voluntarily reported notwithstanding the exemption provided by Rule 16a-9.

F7 · derivative.exercise_date: Award of restricted stock units with respect to GE HealthCare common stock resulting from the conversion of certain equity incentive awards previously granted by GE as a result of the Spin-Off, of which 50% will vest on March 1, 2023 and 50% will vest on March 1, 2024.

F7 · derivative.expiration_date: Award of restricted stock units with respect to GE HealthCare common stock resulting from the conversion of certain equity incentive awards previously granted by GE as a result of the Spin-Off, of which 50% will vest on March 1, 2023 and 50% will vest on March 1, 2024.

SEC source: 0000899243-23-001111 · doc4.xml · derivative · entry 14

O'Neill Kevin Michael · CIK 0001951605 · CEO, PDx

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 6,519

Underlying: Common stock, par value $0.01 per share · 6,519 shares

Expires not disclosed

F4 · derivative.exercise_price: Each restricted stock unit represents the right to receive, at settlement, one share of GE HealthCare common stock.

F1 · price: The transactions reported herein are the result of the consummation on January 3, 2023 of the distribution of approximately 80.1% of the shares of common stock of GE HealthCare Technologies Inc. ("GE HealthCare") by General Electric Company ("GE") to holders of GE common stock on a pro rata basis (the "Spin-Off"). These transactions are voluntarily reported notwithstanding the exemption provided by Rule 16a-9.

F6 · derivative.exercise_date: Award of restricted stock units with respect to GE HealthCare common stock resulting from the conversion of certain equity incentive awards previously granted by GE as a result of the Spin-Off, of which 50% will vest on August 3, 2023 and 50% will vest on August 3, 2024.

F6 · derivative.expiration_date: Award of restricted stock units with respect to GE HealthCare common stock resulting from the conversion of certain equity incentive awards previously granted by GE as a result of the Spin-Off, of which 50% will vest on August 3, 2023 and 50% will vest on August 3, 2024.

SEC source: 0000899243-23-001111 · doc4.xml · derivative · entry 13

O'Neill Kevin Michael · CIK 0001951605 · CEO, PDx

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 1,622

Underlying: Common stock, par value $0.01 per share · 1,622 shares

Expires not disclosed

F4 · derivative.exercise_price: Each restricted stock unit represents the right to receive, at settlement, one share of GE HealthCare common stock.

F1 · price: The transactions reported herein are the result of the consummation on January 3, 2023 of the distribution of approximately 80.1% of the shares of common stock of GE HealthCare Technologies Inc. ("GE HealthCare") by General Electric Company ("GE") to holders of GE common stock on a pro rata basis (the "Spin-Off"). These transactions are voluntarily reported notwithstanding the exemption provided by Rule 16a-9.

F5 · derivative.exercise_date: Award of restricted stock units with respect to GE HealthCare common stock resulting from the conversion of certain equity incentive awards previously granted by GE as a result of the Spin-Off, of which 100% will vest on March 2, 2023.

F5 · derivative.expiration_date: Award of restricted stock units with respect to GE HealthCare common stock resulting from the conversion of certain equity incentive awards previously granted by GE as a result of the Spin-Off, of which 100% will vest on March 2, 2023.

SEC source: 0000899243-23-001111 · doc4.xml · derivative · entry 12

O'Neill Kevin Michael · CIK 0001951605 · CEO, PDx

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 10,820

Underlying: Common stock, par value $0.01 per share · 10,820 shares

Expires 2030-03-02

F1 · price: The transactions reported herein are the result of the consummation on January 3, 2023 of the distribution of approximately 80.1% of the shares of common stock of GE HealthCare Technologies Inc. ("GE HealthCare") by General Electric Company ("GE") to holders of GE common stock on a pro rata basis (the "Spin-Off"). These transactions are voluntarily reported notwithstanding the exemption provided by Rule 16a-9.

F3 · derivative.exercise_date: Award of an employee stock option with respect to GE HealthCare common stock resulting from the conversion of certain equity incentive awards previously granted by GE as a result of the Spin-Off, of which 50% is fully exercisable immediately and 50% will become exercisable on March 2, 2023.

SEC source: 0000899243-23-001111 · doc4.xml · derivative · entry 11

O'Neill Kevin Michael · CIK 0001951605 · CEO, PDx

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 1,614

Underlying: Common stock, par value $0.01 per share · 1,614 shares

Expires 2029-04-11

F1 · price: The transactions reported herein are the result of the consummation on January 3, 2023 of the distribution of approximately 80.1% of the shares of common stock of GE HealthCare Technologies Inc. ("GE HealthCare") by General Electric Company ("GE") to holders of GE common stock on a pro rata basis (the "Spin-Off"). These transactions are voluntarily reported notwithstanding the exemption provided by Rule 16a-9.

F2 · derivative.exercise_date: Award of an employee stock option with respect to GE HealthCare common stock resulting from the conversion of certain equity incentive awards previously granted by GE as a result of the Spin-Off, of which 100% is fully exercisable immediately.

SEC source: 0000899243-23-001111 · doc4.xml · derivative · entry 10

O'Neill Kevin Michael · CIK 0001951605 · CEO, PDx

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 3,106

Underlying: Common stock, par value $0.01 per share · 3,106 shares

Expires 2029-03-19

F1 · price: The transactions reported herein are the result of the consummation on January 3, 2023 of the distribution of approximately 80.1% of the shares of common stock of GE HealthCare Technologies Inc. ("GE HealthCare") by General Electric Company ("GE") to holders of GE common stock on a pro rata basis (the "Spin-Off"). These transactions are voluntarily reported notwithstanding the exemption provided by Rule 16a-9.

F2 · derivative.exercise_date: Award of an employee stock option with respect to GE HealthCare common stock resulting from the conversion of certain equity incentive awards previously granted by GE as a result of the Spin-Off, of which 100% is fully exercisable immediately.

SEC source: 0000899243-23-001111 · doc4.xml · derivative · entry 9

O'Neill Kevin Michael · CIK 0001951605 · CEO, PDx

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 13,275

Underlying: Common stock, par value $0.01 per share · 13,275 shares

Expires 2028-12-21

F1 · price: The transactions reported herein are the result of the consummation on January 3, 2023 of the distribution of approximately 80.1% of the shares of common stock of GE HealthCare Technologies Inc. ("GE HealthCare") by General Electric Company ("GE") to holders of GE common stock on a pro rata basis (the "Spin-Off"). These transactions are voluntarily reported notwithstanding the exemption provided by Rule 16a-9.

F2 · derivative.exercise_date: Award of an employee stock option with respect to GE HealthCare common stock resulting from the conversion of certain equity incentive awards previously granted by GE as a result of the Spin-Off, of which 100% is fully exercisable immediately.

SEC source: 0000899243-23-001111 · doc4.xml · derivative · entry 8

O'Neill Kevin Michael · CIK 0001951605 · CEO, PDx

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 4,592

Underlying: Common stock, par value $0.01 per share · 4,592 shares

Expires 2028-03-19

F1 · price: The transactions reported herein are the result of the consummation on January 3, 2023 of the distribution of approximately 80.1% of the shares of common stock of GE HealthCare Technologies Inc. ("GE HealthCare") by General Electric Company ("GE") to holders of GE common stock on a pro rata basis (the "Spin-Off"). These transactions are voluntarily reported notwithstanding the exemption provided by Rule 16a-9.

F2 · derivative.exercise_date: Award of an employee stock option with respect to GE HealthCare common stock resulting from the conversion of certain equity incentive awards previously granted by GE as a result of the Spin-Off, of which 100% is fully exercisable immediately.

SEC source: 0000899243-23-001111 · doc4.xml · derivative · entry 7

O'Neill Kevin Michael · CIK 0001951605 · CEO, PDx

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 5,877

Underlying: Common stock, par value $0.01 per share · 5,877 shares

Expires 2027-11-17

F1 · price: The transactions reported herein are the result of the consummation on January 3, 2023 of the distribution of approximately 80.1% of the shares of common stock of GE HealthCare Technologies Inc. ("GE HealthCare") by General Electric Company ("GE") to holders of GE common stock on a pro rata basis (the "Spin-Off"). These transactions are voluntarily reported notwithstanding the exemption provided by Rule 16a-9.

F2 · derivative.exercise_date: Award of an employee stock option with respect to GE HealthCare common stock resulting from the conversion of certain equity incentive awards previously granted by GE as a result of the Spin-Off, of which 100% is fully exercisable immediately.

SEC source: 0000899243-23-001111 · doc4.xml · derivative · entry 6

O'Neill Kevin Michael · CIK 0001951605 · CEO, PDx

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 5,051

Underlying: Common stock, par value $0.01 per share · 5,051 shares

Expires 2026-09-30

F1 · price: The transactions reported herein are the result of the consummation on January 3, 2023 of the distribution of approximately 80.1% of the shares of common stock of GE HealthCare Technologies Inc. ("GE HealthCare") by General Electric Company ("GE") to holders of GE common stock on a pro rata basis (the "Spin-Off"). These transactions are voluntarily reported notwithstanding the exemption provided by Rule 16a-9.

F2 · derivative.exercise_date: Award of an employee stock option with respect to GE HealthCare common stock resulting from the conversion of certain equity incentive awards previously granted by GE as a result of the Spin-Off, of which 100% is fully exercisable immediately.

SEC source: 0000899243-23-001111 · doc4.xml · derivative · entry 5

O'Neill Kevin Michael · CIK 0001951605 · CEO, PDx

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 3,672

Underlying: Common stock, par value $0.01 per share · 3,672 shares

Expires 2025-09-11

F1 · price: The transactions reported herein are the result of the consummation on January 3, 2023 of the distribution of approximately 80.1% of the shares of common stock of GE HealthCare Technologies Inc. ("GE HealthCare") by General Electric Company ("GE") to holders of GE common stock on a pro rata basis (the "Spin-Off"). These transactions are voluntarily reported notwithstanding the exemption provided by Rule 16a-9.

F2 · derivative.exercise_date: Award of an employee stock option with respect to GE HealthCare common stock resulting from the conversion of certain equity incentive awards previously granted by GE as a result of the Spin-Off, of which 100% is fully exercisable immediately.

SEC source: 0000899243-23-001111 · doc4.xml · derivative · entry 4

O'Neill Kevin Michael · CIK 0001951605 · CEO, PDx

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 3,329

Underlying: Common stock, par value $0.01 per share · 3,329 shares

Expires 2024-09-05

F1 · price: The transactions reported herein are the result of the consummation on January 3, 2023 of the distribution of approximately 80.1% of the shares of common stock of GE HealthCare Technologies Inc. ("GE HealthCare") by General Electric Company ("GE") to holders of GE common stock on a pro rata basis (the "Spin-Off"). These transactions are voluntarily reported notwithstanding the exemption provided by Rule 16a-9.

F2 · derivative.exercise_date: Award of an employee stock option with respect to GE HealthCare common stock resulting from the conversion of certain equity incentive awards previously granted by GE as a result of the Spin-Off, of which 100% is fully exercisable immediately.

SEC source: 0000899243-23-001111 · doc4.xml · derivative · entry 3

O'Neill Kevin Michael · CIK 0001951605 · CEO, PDx

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 343

Underlying: Common stock, par value $0.01 per share · 343 shares

Expires 2024-09-05

F1 · price: The transactions reported herein are the result of the consummation on January 3, 2023 of the distribution of approximately 80.1% of the shares of common stock of GE HealthCare Technologies Inc. ("GE HealthCare") by General Electric Company ("GE") to holders of GE common stock on a pro rata basis (the "Spin-Off"). These transactions are voluntarily reported notwithstanding the exemption provided by Rule 16a-9.

F2 · derivative.exercise_date: Award of an employee stock option with respect to GE HealthCare common stock resulting from the conversion of certain equity incentive awards previously granted by GE as a result of the Spin-Off, of which 100% is fully exercisable immediately.

SEC source: 0000899243-23-001111 · doc4.xml · derivative · entry 2

O'Neill Kevin Michael · CIK 0001951605 · CEO, PDx

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 1,653

Underlying: Common stock, par value $0.01 per share · 1,653 shares

Expires 2023-09-13

F1 · price: The transactions reported herein are the result of the consummation on January 3, 2023 of the distribution of approximately 80.1% of the shares of common stock of GE HealthCare Technologies Inc. ("GE HealthCare") by General Electric Company ("GE") to holders of GE common stock on a pro rata basis (the "Spin-Off"). These transactions are voluntarily reported notwithstanding the exemption provided by Rule 16a-9.

F2 · derivative.exercise_date: Award of an employee stock option with respect to GE HealthCare common stock resulting from the conversion of certain equity incentive awards previously granted by GE as a result of the Spin-Off, of which 100% is fully exercisable immediately.

SEC source: 0000899243-23-001105 · doc4.xml · derivative · entry 18

Rott Roland · CIK 0001952159 · CEO, Ultrasound

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 5,828

Underlying: Common stock, par value $0.01 per share · 5,828 shares

Expires not disclosed

F5 · derivative.exercise_price: Each restricted stock unit represents the right to receive, at settlement, one share of GE HealthCare common stock.

F1 · price: The transactions reported herein are the result of the consummation on January 3, 2023 of the distribution of approximately 80.1% of the shares of common stock of GE HealthCare Technologies Inc. ("GE HealthCare") by General Electric Company ("GE") to holders of GE common stock on a pro rata basis (the "Spin-Off"). These transactions are voluntarily reported notwithstanding the exemption provided by Rule 16a-9.

F10 · derivative.exercise_date: Award of restricted stock units with respect to GE HealthCare common stock resulting from the conversion of certain equity incentive awards previously granted by GE as a result of the Spin-Off, of which 50% will vest on March 1, 2024 and 50% will vest on March 1, 2025.

F10 · derivative.expiration_date: Award of restricted stock units with respect to GE HealthCare common stock resulting from the conversion of certain equity incentive awards previously granted by GE as a result of the Spin-Off, of which 50% will vest on March 1, 2024 and 50% will vest on March 1, 2025.

SEC source: 0000899243-23-001105 · doc4.xml · derivative · entry 17

Rott Roland · CIK 0001952159 · CEO, Ultrasound

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 3,347

Underlying: Common stock, par value $0.01 per share · 3,347 shares

Expires not disclosed

F5 · derivative.exercise_price: Each restricted stock unit represents the right to receive, at settlement, one share of GE HealthCare common stock.

F1 · price: The transactions reported herein are the result of the consummation on January 3, 2023 of the distribution of approximately 80.1% of the shares of common stock of GE HealthCare Technologies Inc. ("GE HealthCare") by General Electric Company ("GE") to holders of GE common stock on a pro rata basis (the "Spin-Off"). These transactions are voluntarily reported notwithstanding the exemption provided by Rule 16a-9.

F9 · derivative.exercise_date: Award of restricted stock units with respect to GE HealthCare common stock resulting from the conversion of certain equity incentive awards previously granted by GE as a result of the Spin-Off, of which 50% will vest on April 1, 2023 and 50% will vest on April 1, 2024.

F9 · derivative.expiration_date: Award of restricted stock units with respect to GE HealthCare common stock resulting from the conversion of certain equity incentive awards previously granted by GE as a result of the Spin-Off, of which 50% will vest on April 1, 2023 and 50% will vest on April 1, 2024.

SEC source: 0000899243-23-001105 · doc4.xml · derivative · entry 16

Rott Roland · CIK 0001952159 · CEO, Ultrasound

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 3,713

Underlying: Common stock, par value $0.01 per share · 3,713 shares

Expires not disclosed

F5 · derivative.exercise_price: Each restricted stock unit represents the right to receive, at settlement, one share of GE HealthCare common stock.

F1 · price: The transactions reported herein are the result of the consummation on January 3, 2023 of the distribution of approximately 80.1% of the shares of common stock of GE HealthCare Technologies Inc. ("GE HealthCare") by General Electric Company ("GE") to holders of GE common stock on a pro rata basis (the "Spin-Off"). These transactions are voluntarily reported notwithstanding the exemption provided by Rule 16a-9.

F8 · derivative.exercise_date: Award of restricted stock units with respect to GE HealthCare common stock resulting from the conversion of certain equity incentive awards previously granted by GE as a result of the Spin-Off, of which 50% will vest on March 1, 2023 and 50% will vest on March 1, 2024.

F8 · derivative.expiration_date: Award of restricted stock units with respect to GE HealthCare common stock resulting from the conversion of certain equity incentive awards previously granted by GE as a result of the Spin-Off, of which 50% will vest on March 1, 2023 and 50% will vest on March 1, 2024.

SEC source: 0000899243-23-001105 · doc4.xml · derivative · entry 15

Rott Roland · CIK 0001952159 · CEO, Ultrasound

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 6,519

Underlying: Common stock, par value $0.01 per share · 6,519 shares

Expires not disclosed

F5 · derivative.exercise_price: Each restricted stock unit represents the right to receive, at settlement, one share of GE HealthCare common stock.

F1 · price: The transactions reported herein are the result of the consummation on January 3, 2023 of the distribution of approximately 80.1% of the shares of common stock of GE HealthCare Technologies Inc. ("GE HealthCare") by General Electric Company ("GE") to holders of GE common stock on a pro rata basis (the "Spin-Off"). These transactions are voluntarily reported notwithstanding the exemption provided by Rule 16a-9.

F7 · derivative.exercise_date: Award of restricted stock units with respect to GE HealthCare common stock resulting from the conversion of certain equity incentive awards previously granted by GE as a result of the Spin-Off, of which 50% will vest on August 3, 2023 and 50% will vest on August 3, 2024.

F7 · derivative.expiration_date: Award of restricted stock units with respect to GE HealthCare common stock resulting from the conversion of certain equity incentive awards previously granted by GE as a result of the Spin-Off, of which 50% will vest on August 3, 2023 and 50% will vest on August 3, 2024.

SEC source: 0000899243-23-001105 · doc4.xml · derivative · entry 14

Rott Roland · CIK 0001952159 · CEO, Ultrasound

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 1,081

Underlying: Common stock, par value $0.01 per share · 1,081 shares

Expires not disclosed

F5 · derivative.exercise_price: Each restricted stock unit represents the right to receive, at settlement, one share of GE HealthCare common stock.

F1 · price: The transactions reported herein are the result of the consummation on January 3, 2023 of the distribution of approximately 80.1% of the shares of common stock of GE HealthCare Technologies Inc. ("GE HealthCare") by General Electric Company ("GE") to holders of GE common stock on a pro rata basis (the "Spin-Off"). These transactions are voluntarily reported notwithstanding the exemption provided by Rule 16a-9.

F6 · derivative.exercise_date: Award of restricted stock units with respect to GE HealthCare common stock resulting from the conversion of certain equity incentive awards previously granted by GE as a result of the Spin-Off, of which 100% will vest on March 2, 2023.

F6 · derivative.expiration_date: Award of restricted stock units with respect to GE HealthCare common stock resulting from the conversion of certain equity incentive awards previously granted by GE as a result of the Spin-Off, of which 100% will vest on March 2, 2023.

SEC source: 0000899243-23-001105 · doc4.xml · derivative · entry 13

Rott Roland · CIK 0001952159 · CEO, Ultrasound

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 8,536

Underlying: Common stock, par value $0.01 per share · 8,536 shares

Expires 2031-04-01

F1 · price: The transactions reported herein are the result of the consummation on January 3, 2023 of the distribution of approximately 80.1% of the shares of common stock of GE HealthCare Technologies Inc. ("GE HealthCare") by General Electric Company ("GE") to holders of GE common stock on a pro rata basis (the "Spin-Off"). These transactions are voluntarily reported notwithstanding the exemption provided by Rule 16a-9.

F4 · derivative.exercise_date: Award of an employee stock option with respect to GE HealthCare common stock resulting from the conversion of certain equity incentive awards previously granted by GE as a result of the Spin-Off, of which 50% will become exercisable on April 1, 2023 and 50% will become exercisable on April 1, 2024.

SEC source: 0000899243-23-001105 · doc4.xml · derivative · entry 12

Rott Roland · CIK 0001952159 · CEO, Ultrasound

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 7,214

Underlying: Common stock, par value $0.01 per share · 7,214 shares

Expires 2030-03-02

F1 · price: The transactions reported herein are the result of the consummation on January 3, 2023 of the distribution of approximately 80.1% of the shares of common stock of GE HealthCare Technologies Inc. ("GE HealthCare") by General Electric Company ("GE") to holders of GE common stock on a pro rata basis (the "Spin-Off"). These transactions are voluntarily reported notwithstanding the exemption provided by Rule 16a-9.

F3 · derivative.exercise_date: Award of an employee stock option with respect to GE HealthCare common stock resulting from the conversion of certain equity incentive awards previously granted by GE as a result of the Spin-Off, of which 50% is exercisable immediately and 50% will become exercisable on March 2, 2023.

SEC source: 0000899243-23-001105 · doc4.xml · derivative · entry 11

Rott Roland · CIK 0001952159 · CEO, Ultrasound

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 1,614

Underlying: Common stock, par value $0.01 per share · 1,614 shares

Expires 2029-04-11

F1 · price: The transactions reported herein are the result of the consummation on January 3, 2023 of the distribution of approximately 80.1% of the shares of common stock of GE HealthCare Technologies Inc. ("GE HealthCare") by General Electric Company ("GE") to holders of GE common stock on a pro rata basis (the "Spin-Off"). These transactions are voluntarily reported notwithstanding the exemption provided by Rule 16a-9.

F2 · derivative.exercise_date: Award of an employee stock option with respect to GE HealthCare common stock resulting from the conversion of certain equity incentive awards previously granted by GE as a result of the Spin-Off, of which 100% is fully exercisable immediately.

SEC source: 0000899243-23-001105 · doc4.xml · derivative · entry 10

Rott Roland · CIK 0001952159 · CEO, Ultrasound

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 3,727

Underlying: Common stock, par value $0.01 per share · 3,727 shares

Expires 2029-03-19

F1 · price: The transactions reported herein are the result of the consummation on January 3, 2023 of the distribution of approximately 80.1% of the shares of common stock of GE HealthCare Technologies Inc. ("GE HealthCare") by General Electric Company ("GE") to holders of GE common stock on a pro rata basis (the "Spin-Off"). These transactions are voluntarily reported notwithstanding the exemption provided by Rule 16a-9.

F2 · derivative.exercise_date: Award of an employee stock option with respect to GE HealthCare common stock resulting from the conversion of certain equity incentive awards previously granted by GE as a result of the Spin-Off, of which 100% is fully exercisable immediately.

SEC source: 0000899243-23-001105 · doc4.xml · derivative · entry 9

Rott Roland · CIK 0001952159 · CEO, Ultrasound

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 13,275

Underlying: Common stock, par value $0.01 per share · 13,275 shares

Expires 2028-12-21

F1 · price: The transactions reported herein are the result of the consummation on January 3, 2023 of the distribution of approximately 80.1% of the shares of common stock of GE HealthCare Technologies Inc. ("GE HealthCare") by General Electric Company ("GE") to holders of GE common stock on a pro rata basis (the "Spin-Off"). These transactions are voluntarily reported notwithstanding the exemption provided by Rule 16a-9.

F2 · derivative.exercise_date: Award of an employee stock option with respect to GE HealthCare common stock resulting from the conversion of certain equity incentive awards previously granted by GE as a result of the Spin-Off, of which 100% is fully exercisable immediately.

SEC source: 0000899243-23-001105 · doc4.xml · derivative · entry 8

Rott Roland · CIK 0001952159 · CEO, Ultrasound

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 2,296

Underlying: Common stock, par value $0.01 per share · 2,296 shares

Expires 2028-03-19

F1 · price: The transactions reported herein are the result of the consummation on January 3, 2023 of the distribution of approximately 80.1% of the shares of common stock of GE HealthCare Technologies Inc. ("GE HealthCare") by General Electric Company ("GE") to holders of GE common stock on a pro rata basis (the "Spin-Off"). These transactions are voluntarily reported notwithstanding the exemption provided by Rule 16a-9.

F2 · derivative.exercise_date: Award of an employee stock option with respect to GE HealthCare common stock resulting from the conversion of certain equity incentive awards previously granted by GE as a result of the Spin-Off, of which 100% is fully exercisable immediately.

SEC source: 0000899243-23-001105 · doc4.xml · derivative · entry 7

Rott Roland · CIK 0001952159 · CEO, Ultrasound

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 1,639

Underlying: Common stock, par value $0.01 per share · 1,639 shares

Expires 2028-03-19

F1 · price: The transactions reported herein are the result of the consummation on January 3, 2023 of the distribution of approximately 80.1% of the shares of common stock of GE HealthCare Technologies Inc. ("GE HealthCare") by General Electric Company ("GE") to holders of GE common stock on a pro rata basis (the "Spin-Off"). These transactions are voluntarily reported notwithstanding the exemption provided by Rule 16a-9.

F2 · derivative.exercise_date: Award of an employee stock option with respect to GE HealthCare common stock resulting from the conversion of certain equity incentive awards previously granted by GE as a result of the Spin-Off, of which 100% is fully exercisable immediately.

SEC source: 0000899243-23-001105 · doc4.xml · derivative · entry 6

Rott Roland · CIK 0001952159 · CEO, Ultrasound

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 13,773

Underlying: Common stock, par value $0.01 per share · 13,773 shares

Expires 2028-01-29

F1 · price: The transactions reported herein are the result of the consummation on January 3, 2023 of the distribution of approximately 80.1% of the shares of common stock of GE HealthCare Technologies Inc. ("GE HealthCare") by General Electric Company ("GE") to holders of GE common stock on a pro rata basis (the "Spin-Off"). These transactions are voluntarily reported notwithstanding the exemption provided by Rule 16a-9.

F2 · derivative.exercise_date: Award of an employee stock option with respect to GE HealthCare common stock resulting from the conversion of certain equity incentive awards previously granted by GE as a result of the Spin-Off, of which 100% is fully exercisable immediately.

SEC source: 0000899243-23-001105 · doc4.xml · derivative · entry 5

Rott Roland · CIK 0001952159 · CEO, Ultrasound

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 919

Underlying: Common stock, par value $0.01 per share · 919 shares

Expires 2027-11-17

F1 · price: The transactions reported herein are the result of the consummation on January 3, 2023 of the distribution of approximately 80.1% of the shares of common stock of GE HealthCare Technologies Inc. ("GE HealthCare") by General Electric Company ("GE") to holders of GE common stock on a pro rata basis (the "Spin-Off"). These transactions are voluntarily reported notwithstanding the exemption provided by Rule 16a-9.

F2 · derivative.exercise_date: Award of an employee stock option with respect to GE HealthCare common stock resulting from the conversion of certain equity incentive awards previously granted by GE as a result of the Spin-Off, of which 100% is fully exercisable immediately.

SEC source: 0000899243-23-001105 · doc4.xml · derivative · entry 4

Rott Roland · CIK 0001952159 · CEO, Ultrasound

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 552

Underlying: Common stock, par value $0.01 per share · 552 shares

Expires 2026-09-30

F1 · price: The transactions reported herein are the result of the consummation on January 3, 2023 of the distribution of approximately 80.1% of the shares of common stock of GE HealthCare Technologies Inc. ("GE HealthCare") by General Electric Company ("GE") to holders of GE common stock on a pro rata basis (the "Spin-Off"). These transactions are voluntarily reported notwithstanding the exemption provided by Rule 16a-9.

F2 · derivative.exercise_date: Award of an employee stock option with respect to GE HealthCare common stock resulting from the conversion of certain equity incentive awards previously granted by GE as a result of the Spin-Off, of which 100% is fully exercisable immediately.

SEC source: 0000899243-23-001105 · doc4.xml · derivative · entry 3

Rott Roland · CIK 0001952159 · CEO, Ultrasound

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 735

Underlying: Common stock, par value $0.01 per share · 735 shares

Expires 2025-09-11

F1 · price: The transactions reported herein are the result of the consummation on January 3, 2023 of the distribution of approximately 80.1% of the shares of common stock of GE HealthCare Technologies Inc. ("GE HealthCare") by General Electric Company ("GE") to holders of GE common stock on a pro rata basis (the "Spin-Off"). These transactions are voluntarily reported notwithstanding the exemption provided by Rule 16a-9.

F2 · derivative.exercise_date: Award of an employee stock option with respect to GE HealthCare common stock resulting from the conversion of certain equity incentive awards previously granted by GE as a result of the Spin-Off, of which 100% is fully exercisable immediately.

SEC source: 0000899243-23-001105 · doc4.xml · derivative · entry 2

Rott Roland · CIK 0001952159 · CEO, Ultrasound

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 643

Underlying: Common stock, par value $0.01 per share · 643 shares

Expires 2024-09-05

F1 · price: The transactions reported herein are the result of the consummation on January 3, 2023 of the distribution of approximately 80.1% of the shares of common stock of GE HealthCare Technologies Inc. ("GE HealthCare") by General Electric Company ("GE") to holders of GE common stock on a pro rata basis (the "Spin-Off"). These transactions are voluntarily reported notwithstanding the exemption provided by Rule 16a-9.

F2 · derivative.exercise_date: Award of an employee stock option with respect to GE HealthCare common stock resulting from the conversion of certain equity incentive awards previously granted by GE as a result of the Spin-Off, of which 100% is fully exercisable immediately.

SEC source: 0000899243-23-001104 · doc4.xml · derivative · entry 12

Westrick Thomas J. · CIK 0001952674 · CEO, Patient Care Solutions

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 5,464

Underlying: Common stock, par value $0.01 per share · 5,464 shares

Expires not disclosed

F3 · derivative.exercise_price: Each restricted stock unit represents the right to receive, at settlement, one share of GE HealthCare common stock.

F6 · price: Award of restricted stock units with respect to GE HealthCare common stock resulting from the conversion of certain equity incentive awards previously granted by GE as a result of the Spin-Off, of which 50% will vest on March 1, 2024 and 50% will vest on March 1, 2025.

F6 · derivative.exercise_date: Award of restricted stock units with respect to GE HealthCare common stock resulting from the conversion of certain equity incentive awards previously granted by GE as a result of the Spin-Off, of which 50% will vest on March 1, 2024 and 50% will vest on March 1, 2025.

F6 · derivative.expiration_date: Award of restricted stock units with respect to GE HealthCare common stock resulting from the conversion of certain equity incentive awards previously granted by GE as a result of the Spin-Off, of which 50% will vest on March 1, 2024 and 50% will vest on March 1, 2025.

SEC source: 0000899243-23-001104 · doc4.xml · derivative · entry 11

Westrick Thomas J. · CIK 0001952674 · CEO, Patient Care Solutions

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 5,568

Underlying: Common stock, par value $0.01 per share · 5,568 shares

Expires not disclosed

F3 · derivative.exercise_price: Each restricted stock unit represents the right to receive, at settlement, one share of GE HealthCare common stock.

F5 · price: Award of restricted stock units with respect to GE HealthCare common stock resulting from the conversion of certain equity incentive awards previously granted by GE as a result of the Spin-Off, of which 50% will vest on March 1, 2023 and 50% will vest on March 1, 2024.

F5 · derivative.exercise_date: Award of restricted stock units with respect to GE HealthCare common stock resulting from the conversion of certain equity incentive awards previously granted by GE as a result of the Spin-Off, of which 50% will vest on March 1, 2023 and 50% will vest on March 1, 2024.

F5 · derivative.expiration_date: Award of restricted stock units with respect to GE HealthCare common stock resulting from the conversion of certain equity incentive awards previously granted by GE as a result of the Spin-Off, of which 50% will vest on March 1, 2023 and 50% will vest on March 1, 2024.

SEC source: 0000899243-23-001104 · doc4.xml · derivative · entry 10

Westrick Thomas J. · CIK 0001952674 · CEO, Patient Care Solutions

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 1,513

Underlying: Common stock, par value $0.01 per share · 1,513 shares

Expires not disclosed

F3 · derivative.exercise_price: Each restricted stock unit represents the right to receive, at settlement, one share of GE HealthCare common stock.

F4 · price: Award of restricted stock units with respect to GE HealthCare common stock resulting from the conversion of certain equity incentive awards previously granted by GE as a result of the Spin-Off, of which 100% will vest on March 2, 2023.

F4 · derivative.exercise_date: Award of restricted stock units with respect to GE HealthCare common stock resulting from the conversion of certain equity incentive awards previously granted by GE as a result of the Spin-Off, of which 100% will vest on March 2, 2023.

F4 · derivative.expiration_date: Award of restricted stock units with respect to GE HealthCare common stock resulting from the conversion of certain equity incentive awards previously granted by GE as a result of the Spin-Off, of which 100% will vest on March 2, 2023.

SEC source: 0000899243-23-001104 · doc4.xml · derivative · entry 9

Westrick Thomas J. · CIK 0001952674 · CEO, Patient Care Solutions

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 13,465

Underlying: Common stock, par value $0.01 per share · 13,465 shares

Expires 2030-03-02

F2 · price: Award of an employee stock option with respect to GE HealthCare common stock resulting from the conversion of certain equity incentive awards previously granted by GE as a result of the Spin-Off, of which 50% is exercisable immediately and 50% will become exercisable on March 2, 2023.

F2 · derivative.exercise_date: Award of an employee stock option with respect to GE HealthCare common stock resulting from the conversion of certain equity incentive awards previously granted by GE as a result of the Spin-Off, of which 50% is exercisable immediately and 50% will become exercisable on March 2, 2023.

SEC source: 0000899243-23-001104 · doc4.xml · derivative · entry 8

Westrick Thomas J. · CIK 0001952674 · CEO, Patient Care Solutions

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 3,229

Underlying: Common stock, par value $0.01 per share · 3,229 shares

Expires 2029-04-11

F1 · price: Award of an employee stock option with respect to GE HealthCare Technologies Inc. ("GE HealthCare") common stock resulting from the conversion of certain equity incentive awards previously granted by General Electric Company ("GE") as a result of the consummation on January 3, 2023 of the distribution of approximately 80.1% of the shares of common stock of GE HealthCare by GE to holders of GE common stock on a pro rata basis (the "Spin-Off"), of which 100% is fully exercisable immediately.

F1 · derivative.exercise_date: Award of an employee stock option with respect to GE HealthCare Technologies Inc. ("GE HealthCare") common stock resulting from the conversion of certain equity incentive awards previously granted by General Electric Company ("GE") as a result of the consummation on January 3, 2023 of the distribution of approximately 80.1% of the shares of common stock of GE HealthCare by GE to holders of GE common stock on a pro rata basis (the "Spin-Off"), of which 100% is fully exercisable immediately.

SEC source: 0000899243-23-001104 · doc4.xml · derivative · entry 7

Westrick Thomas J. · CIK 0001952674 · CEO, Patient Care Solutions

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 23,725

Underlying: Common stock, par value $0.01 per share · 23,725 shares

Expires 2028-12-21

F1 · price: Award of an employee stock option with respect to GE HealthCare Technologies Inc. ("GE HealthCare") common stock resulting from the conversion of certain equity incentive awards previously granted by General Electric Company ("GE") as a result of the consummation on January 3, 2023 of the distribution of approximately 80.1% of the shares of common stock of GE HealthCare by GE to holders of GE common stock on a pro rata basis (the "Spin-Off"), of which 100% is fully exercisable immediately.

F1 · derivative.exercise_date: Award of an employee stock option with respect to GE HealthCare Technologies Inc. ("GE HealthCare") common stock resulting from the conversion of certain equity incentive awards previously granted by General Electric Company ("GE") as a result of the consummation on January 3, 2023 of the distribution of approximately 80.1% of the shares of common stock of GE HealthCare by GE to holders of GE common stock on a pro rata basis (the "Spin-Off"), of which 100% is fully exercisable immediately.

SEC source: 0000899243-23-001104 · doc4.xml · derivative · entry 6

Westrick Thomas J. · CIK 0001952674 · CEO, Patient Care Solutions

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 9,312

Underlying: Common stock, par value $0.01 per share · 9,312 shares

Expires 2028-03-19

F1 · price: Award of an employee stock option with respect to GE HealthCare Technologies Inc. ("GE HealthCare") common stock resulting from the conversion of certain equity incentive awards previously granted by General Electric Company ("GE") as a result of the consummation on January 3, 2023 of the distribution of approximately 80.1% of the shares of common stock of GE HealthCare by GE to holders of GE common stock on a pro rata basis (the "Spin-Off"), of which 100% is fully exercisable immediately.

F1 · derivative.exercise_date: Award of an employee stock option with respect to GE HealthCare Technologies Inc. ("GE HealthCare") common stock resulting from the conversion of certain equity incentive awards previously granted by General Electric Company ("GE") as a result of the consummation on January 3, 2023 of the distribution of approximately 80.1% of the shares of common stock of GE HealthCare by GE to holders of GE common stock on a pro rata basis (the "Spin-Off"), of which 100% is fully exercisable immediately.

SEC source: 0000899243-23-001104 · doc4.xml · derivative · entry 5

Westrick Thomas J. · CIK 0001952674 · CEO, Patient Care Solutions

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 17,446

Underlying: Common stock, par value $0.01 per share · 17,446 shares

Expires 2027-11-17

F1 · price: Award of an employee stock option with respect to GE HealthCare Technologies Inc. ("GE HealthCare") common stock resulting from the conversion of certain equity incentive awards previously granted by General Electric Company ("GE") as a result of the consummation on January 3, 2023 of the distribution of approximately 80.1% of the shares of common stock of GE HealthCare by GE to holders of GE common stock on a pro rata basis (the "Spin-Off"), of which 100% is fully exercisable immediately.

F1 · derivative.exercise_date: Award of an employee stock option with respect to GE HealthCare Technologies Inc. ("GE HealthCare") common stock resulting from the conversion of certain equity incentive awards previously granted by General Electric Company ("GE") as a result of the consummation on January 3, 2023 of the distribution of approximately 80.1% of the shares of common stock of GE HealthCare by GE to holders of GE common stock on a pro rata basis (the "Spin-Off"), of which 100% is fully exercisable immediately.

SEC source: 0000899243-23-001104 · doc4.xml · derivative · entry 4

Westrick Thomas J. · CIK 0001952674 · CEO, Patient Care Solutions

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 7,804

Underlying: Common stock, par value $0.01 per share · 7,804 shares

Expires 2026-09-30

F1 · price: Award of an employee stock option with respect to GE HealthCare Technologies Inc. ("GE HealthCare") common stock resulting from the conversion of certain equity incentive awards previously granted by General Electric Company ("GE") as a result of the consummation on January 3, 2023 of the distribution of approximately 80.1% of the shares of common stock of GE HealthCare by GE to holders of GE common stock on a pro rata basis (the "Spin-Off"), of which 100% is fully exercisable immediately.

F1 · derivative.exercise_date: Award of an employee stock option with respect to GE HealthCare Technologies Inc. ("GE HealthCare") common stock resulting from the conversion of certain equity incentive awards previously granted by General Electric Company ("GE") as a result of the consummation on January 3, 2023 of the distribution of approximately 80.1% of the shares of common stock of GE HealthCare by GE to holders of GE common stock on a pro rata basis (the "Spin-Off"), of which 100% is fully exercisable immediately.

SEC source: 0000899243-23-001104 · doc4.xml · derivative · entry 3

Westrick Thomas J. · CIK 0001952674 · CEO, Patient Care Solutions

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 13,773

Underlying: Common stock, par value $0.01 per share · 13,773 shares

Expires 2025-09-11

F1 · price: Award of an employee stock option with respect to GE HealthCare Technologies Inc. ("GE HealthCare") common stock resulting from the conversion of certain equity incentive awards previously granted by General Electric Company ("GE") as a result of the consummation on January 3, 2023 of the distribution of approximately 80.1% of the shares of common stock of GE HealthCare by GE to holders of GE common stock on a pro rata basis (the "Spin-Off"), of which 100% is fully exercisable immediately.

F1 · derivative.exercise_date: Award of an employee stock option with respect to GE HealthCare Technologies Inc. ("GE HealthCare") common stock resulting from the conversion of certain equity incentive awards previously granted by General Electric Company ("GE") as a result of the consummation on January 3, 2023 of the distribution of approximately 80.1% of the shares of common stock of GE HealthCare by GE to holders of GE common stock on a pro rata basis (the "Spin-Off"), of which 100% is fully exercisable immediately.

SEC source: 0000899243-23-001104 · doc4.xml · derivative · entry 2

Westrick Thomas J. · CIK 0001952674 · CEO, Patient Care Solutions

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 13,773

Underlying: Common stock, par value $0.01 per share · 13,773 shares

Expires 2024-09-05

F1 · price: Award of an employee stock option with respect to GE HealthCare Technologies Inc. ("GE HealthCare") common stock resulting from the conversion of certain equity incentive awards previously granted by General Electric Company ("GE") as a result of the consummation on January 3, 2023 of the distribution of approximately 80.1% of the shares of common stock of GE HealthCare by GE to holders of GE common stock on a pro rata basis (the "Spin-Off"), of which 100% is fully exercisable immediately.

F1 · derivative.exercise_date: Award of an employee stock option with respect to GE HealthCare Technologies Inc. ("GE HealthCare") common stock resulting from the conversion of certain equity incentive awards previously granted by General Electric Company ("GE") as a result of the consummation on January 3, 2023 of the distribution of approximately 80.1% of the shares of common stock of GE HealthCare by GE to holders of GE common stock on a pro rata basis (the "Spin-Off"), of which 100% is fully exercisable immediately.

SEC source: 0000899243-23-001104 · doc4.xml · derivative · entry 1

Westrick Thomas J. · CIK 0001952674 · CEO, Patient Care Solutions

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 9,733

Underlying: Common stock, par value $0.01 per share · 9,733 shares

Expires 2023-09-13

F1 · price: Award of an employee stock option with respect to GE HealthCare Technologies Inc. ("GE HealthCare") common stock resulting from the conversion of certain equity incentive awards previously granted by General Electric Company ("GE") as a result of the consummation on January 3, 2023 of the distribution of approximately 80.1% of the shares of common stock of GE HealthCare by GE to holders of GE common stock on a pro rata basis (the "Spin-Off"), of which 100% is fully exercisable immediately.

F1 · derivative.exercise_date: Award of an employee stock option with respect to GE HealthCare Technologies Inc. ("GE HealthCare") common stock resulting from the conversion of certain equity incentive awards previously granted by General Electric Company ("GE") as a result of the consummation on January 3, 2023 of the distribution of approximately 80.1% of the shares of common stock of GE HealthCare by GE to holders of GE common stock on a pro rata basis (the "Spin-Off"), of which 100% is fully exercisable immediately.

SEC source: 0000899243-23-001102 · doc4.xml · derivative · entry 4

Zodl Helmut · CIK 0001951654 · Chief Financial Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 11,654

Underlying: Common stock, par value $0.01 per share · 11,654 shares

Expires not disclosed

F1 · derivative.exercise_price: Each restricted stock unit represents the right to receive, at settlement, one share of common stock of GE HealthCare Technologies Inc. ("GE HealthCare").

F5 · price: Award of restricted stock units with respect to GE HealthCare common stock resulting from the conversion of certain equity incentive awards previously granted by GE as a result of the Spin-Off, of which 50% will vest on March 1, 2024 and 50% will vest on March 1, 2025.

F5 · derivative.exercise_date: Award of restricted stock units with respect to GE HealthCare common stock resulting from the conversion of certain equity incentive awards previously granted by GE as a result of the Spin-Off, of which 50% will vest on March 1, 2024 and 50% will vest on March 1, 2025.

F5 · derivative.expiration_date: Award of restricted stock units with respect to GE HealthCare common stock resulting from the conversion of certain equity incentive awards previously granted by GE as a result of the Spin-Off, of which 50% will vest on March 1, 2024 and 50% will vest on March 1, 2025.